Abstract
The study of Complex Regional Pain Syndrome (CRPS) in humans is complicated by inhomogeneities in available study cohorts. We hoped to characterize early CRPS-like features in patients undergoing hand surgery. Forty-three patients were recruited from a hand surgery clinic that had elective surgeries followed by cast immobilization. On the day of cast removal, patients were assessed for vasomotor, sudomotor, and trophic changes, edema and pain sensitization using quantitative sensory testing. Pain intensity was assessed at the time of cast removal and after one additional month as was the nature of the pain using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS). Skin biopsies were harvested for the analysis of expression of inflammatory mediators. We identified vascular and trophic changes in the surgical hands of most patients. Increased sensitivity to punctate, pressure and cold stimuli were observed commonly as well. Moreover, levels of IL-6, TNF-alpha and the mast cell marker tryptase were elevated in the skin of hands ipsilateral to surgery. Moderate to severe pain persisted in the surgical hands for up to one month after cast removal. Exploratory analyses suggested interrelationships between the physical, QST and gene expression changes and pain related outcomes.
Keywords: Complex Regional Pain Syndrome, Pain, Cytokine, Nerve Growth Factor, Quantitative Sensory Testing
Introduction
Complex regional pain syndrome (CRPS) is a painful, disabling and often chronic condition principally affecting the extremities. While acute CRPS sometimes improves spontaneously or with aggressive physical therapy, CRPS present for a period of one year or greater seldom spontaneously resolves 33, and worsens in many patients from years 1 to 8 after onset 42. Trauma to the distal extremities is a frequent cause of CRPS 43. For example, the estimated incidence of CRPS after extremity surgery depends to a degree on the specific procedure, but by all accounts the problem is common. The rate of CRPS is 8.3% after carpal tunnel surgery 9 and greater than 30% after distal radius fracture in some series 2. Immobilization in the setting of trauma is a widely recognized factor predisposing patients to the development of CRPS with 47% of all CRPS sufferers in one study having a history of medically imposed limb immobilization 1. Moreover, the nature of the syndrome is dynamic. The affected limb often progresses through an acute phase in which the limb is sensitive, swollen and displays an elevated temperature to a chronic phase in which the inflamed appearance has resolved, but the pain and disability remain6.
The heterogeneous nature of CRPS both in terms of etiology and duration in available study populations has made the study of the syndrome and its treatments challenging. This has led to the assembly of clinical research networks, the identification of new animal models, and the development of new approaches to the use of human subjects. One innovative approach to assembling more suitable study populations has been to model CRPS in humans without inducing the formal clinical syndrome. The application of a thumb spica cast to the upper extremity of healthy volunteers for four weeks caused warmth and sensitization to both cold stimuli and skin fold pressure in the casted limb reminiscent of acute CRPS39, as well as changes in capsaicin-induced neurogenic inflammation40. In neither published report using the cast immobilization technique did a subject develop clinical CRPS. While clearly a useful model, this volunteer procedure requires a healthy individual to wear a cast for four weeks, and, unlike most cases of CRPS, does not involve trauma to the affected limb.
We sought to identify CRPS-like changes in the limbs of patients undergoing extremity surgery followed by immobilization. We hypothesized that patients undergoing hand surgery, a population at high risk for developing CRPS, would in fact display vascular, trophic and nociceptive changes at the time of cast removal similar to those with acute CRPS, and that some patients would exhibit persistent changes. Furthermore, we hypothesized that postsurgical patients would express elevated cutaneous levels of IL-1β, IL-6, TNFα, NGF and tryptase, based on previous studies looking at elevated inflammatory mediator expression in CRPS patient skin blister fluid and skin biopsies 17, 20, 28, and skin from a rat fracture/cast immobilization model of CRPS 22, 30. The advantages of using such a population to study specific features of acute CRPS include, 1) the lack of requirement for an inconvenient or potentially harmful intervention to generate the model, 2) the homogeneity of the circumstances leading to the pathophysiological features under study, 3) the potential opportunity to study the progression or resolution of changes in the surgical limb, and 4) the potential ability to study interventions applied either during the early post-surgical period or immediately following cast removal.
Methods
Participants
The study protocol was first approved by the local Institutional Review Board. Forty-three participants were recruited from the weekly Hand and Upper Extremity clinic at the VA Hospital in Palo Alto CA. Five women and thirty-eight men were enrolled after giving written informed consent. The principal inclusion criteria were: 1) ages 18 – 75, and 2) status post hand/wrist surgery and cast immobilization of ≥ 12 days and available for testing within 36 hours of cast removal. The principal exclusion criteria were: 1) ongoing infection in either hand, 2) anticoagulation with agents other than aspirin, 3) neurological deficits potentially interfering with pain testing, neuropathic pain or a history of complex regional pain syndrome, and 4) history of inflammatory skin diseases (psoriasis, dermatitis, etc.).
Study Setting
Participants were met in the Hand and Upper Extremity clinic after their cast removal clinic appointment and were escorted to a private clinic space for enrollment and testing. The room was uniformly lit and temperature controlled to 21°C. A single research coordinator (AP) interacted with the study participants, performed all testing procedures and collected all subjective data. Participants were seated at a table across from the research coordinator for all testing. For participants who elected to have a skin biopsy, procedure was performed immediately after the conclusion of sensory testing in the same room. Follow up phone calls were arranged for 28 days following cast removal.
Surgical and medical information
After providing written informed consent, the date, type, and location of surgery were collected in addition to any complications since the surgery. Hand dominance was recorded. The patients were queried as to pre and postoperative pain medication use and duration of use, and these results were checked against the electronic medical record. The medical record was also reviewed for ongoing use of angiotensin converting enzyme inhibitors (ACE inhibitors). Histories of psychological disease were recorded.
Pain intensity and characteristics
The nociceptive versus neuropathic nature of the patient’s pain was assessed using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) 4. For assessment upon phone follow-up, we used the short form of the LANSS (S-LANSS) which has similar sensitivity and discriminatory properties to the parent scale, and a specificity of approximately 80%5.
Pain intensity was assessed on the day of cast removal and one month later in both the surgical and contralateral hands.
Average pain - At the time of cast removal and one month later average pain from the preceding 7 days was assessed using a verbally administered 0–10 numerical rating scale (NRS). This scale is both sensitive and has relatively robust statistical properties 44.
Dynamic pain - At the time of cast removal and one month later pain experienced immediately after opening/closing the hand to make a fist 4 times excluding movement of any digits involved in surgery was assessed using the 0–10 NRS scale.
Physical observations
Both distal forearms and hands were visually assessed for erythema, difference in hair growth, difference in nail texture and sweating. All observational and pain testing measurements were conducted first on the contra lateral hand followed by the surgical hand.
Temperature - The temperature at 3 locations (center of the dorsum, pulp of digit 3, and the center of the palm) was recorded with an infrared thermometer (Exergen DT-1000 Infrared Dermal Thermometer, Exergen Corp, Watertown MA USA).
Edema - Hands were assessed for edema using a flexible measuring tape and the figure-of-eight measurement technique to quantify circumference. This method has sensitivity and inter-tester reliability similar to that of standard volumetry21.
Mechanical allodynia - To assess allodynia, a cotton ball was lightly brushed three times along the dorsum of the contra lateral hand as described by Bennett 4. Participants were asked if this was a normal sensation. The cotton ball was then lightly brushed three times along the dorsum of the operative hand at least 4cm distant from the surgical incisions and asked whether this was a normal sensation or unpleasant or unusual in any way, e.g. by evoking tingling or nausea. Unpleasant sensation experienced in the surgical hand was recorded as allodynia.
Quantitative sensory testing
The QST modalities tested reflected some of those most robustly changed in reports involving large CRPS patient cohorts and in a previously reported human model of CRPS involving cast immobilization 14, 39.
Punctate mechanical pain - Punctate mechanical pain thresholds were measured on the dorsum of the hand at least 4 cm distant from the operative location. These measurements were accomplished using an electronic von Frey anesthesiometer (Electronic von Frey Anesthesiometer model 2390, IITC INC. Life Science, Woodland Hills, CA USA) fitted with a supplied rigid tip. During testing, the palm of the hand rested on a solid surface. The von Frey anesthesiometer was pressed perpendicularly against the skin of the dorsum, and pressure was applied at a constant rate until pain was reported. The thresholds were determined by averaging three individual measurements on each hand assessed in matched locations.
Joint pressure pain – Joint pressure pain thresholds were tested in the MCP joints of digits 2–4 of the contralateral and surgical/immobilized hand. This was performed with a pressure algometer (Commander, JTECH Medical, Salt Lake City, Utah, USA). During testing, the palm of the hand rested on a solid surface. The rod with a curved fingertip attachment was pressed perpendicularly against the skin above the MCP joints, and pressure applied at a constant rate of 2N/s until pain was reported. Three measurements per joint were made and all measurements averaged for each hand.
Interdigital skin fold pressure pain – The pressure algometer described above fitted with a 1cm2 rubber-tipped rod was used to assess pressure pain on a dermal fold between digits. The skin between digits 2 and 3 was used as the larger first interdigital skin fold was often within a few centimeters of the surgical area. Participants’ palms rested against a solid surface with fingers slightly abducted. The pressure algometer was pressed perpendicularly against the skin between the digits at a constant rate (2N/s) until pain was reported. Three measurements per hand were made and measurements averaged for each hand.
Cold Hyperalgesia – Cold pain thresholds (CPT) was assessed using a thermal sensory analyzer and a 32×32mm probe (Medoc TSA 2001 thermal sensory analyzer probe, Medoc Instruments Ramat, Yishai Israel). During testing the palm of the hand being tested rested on a solid surface while the research coordinator held the probe against the dorsum. The participants’ contralateral hand operated a mouse to stop cooling when cold pain was first sensed. For determination of CPT, five successive stimulations starting from a baseline temperature of 32°C decreasing by 1 degree per seco nd were averaged for each hand.
Skin Biopsy
Participants were presented with the option of participating in the skin biopsy portion of the study. If the subject elected to undergo biopsies, the procedures were performed directly after completion of other testing. One 3mm punch biopsy was collected from the dorsum of each hand with the surgical hand biopsy at least 4cm from any incision using a commercially available kit (Acuderm Inc. Ft Lauderdale, FL). The biopsy sites were cleaned with alcohol and a small amount of 1% lidocaine was injected via a 30ga needle. A 3mm disposable punch biopsy instrument was used. Inward pressure was placed on the instrument while it was rotated. When subcutaneous fat was reached, the instrument was removed. The circular biopsy was elevated and the base freed using an iris scissor. Pressure was applied to assure hemostasis. Topical antibiotic was applied and a small bandage placed. No sutures were necessary.
Tissue Processing and Quantification of Gene Expression
Immediately after harvest, the skin biopsies were stored in RNAlater stabilization reagent solution (Qiagen, Valencia, CA) for 1 to 4 months at −80°C. Total RNA from the samples was the n extracted using RNeasy Micro Kit (Qiagen, Valencia, CA) and quantified using a NanoDrop ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies, Wilmington, DE). At that point cDNA (20 μL final volume) was synthesized from 500 ng RNA using a quantiTect Reverse Transcription Kit (Qiagen, Valencia, CA). Real-time polymerase chain reactions (PCRs) were performed with fluorescent probes using either QuantiFast duplex PCR detection kits (Qiagen, Valencia, CA) or QuantiTect SYBR Green-based real-time PCR Kit (Qiagen, Valencia, CA) in ABI PRISM 7900HT Sequence Detection System (Life Technologies, Grand Island, NY) according to the manufacturer’s instructions. TNF-α, TPSAB-1 (tryptase), NGF, IL-1β, and IL-6 transcripts were individually subjected to duplex analyses with GAPDH using two different florescent dyes, while IL-1β and GAPDH were detected by separate reactions with singleplex expression analyses for each dye. To validate the primer sets used, we performed dissociation curves to document single product formation. The data were analyzed by the comparative CT (cycle threshold) method, as described in the manufacturer's manual. All assays were performed in triplicate for each sample.
Data Handling and Statistical Analysis
The patient database was kept on password protected equipment in a locked room, and data files on portable devices were encrypted. The data security plan was approved by the Institutional Review Board. Statistical analysis of data and the preparation of data plots were performed using Prism 5 software (Graphpad Software, LaJolla, CA). Comparisons of mean values for parametric data were conducted using t-testing. Correlational analysis was conducted using the Pearson approach for parametric data and the Spearman approach for non-parametric data, e.g. LANSS scores. Data are presented as means +/− standard deviation or as box and whisker plots. The minimum level of significance was p<0.05.
Results
Demographics and treatment characteristics of the study cohort
Our study cohort consisted of 43 patients attending a hand surgery clinic at a single medical center. Most patients were middle aged, and strong bias existed towards male participants characteristic of a Veteran’s Affairs medical center (Table 1). Approximately one third of the patient cohort had a psychiatric diagnosis of depression or anxiety at the time of surgery. The most common procedures performed on the patients included carpometacarpal arthroplasty for degenerative disease followed by stabilization of fractures involving the hand, bone fusion procedures and soft tissue operations such as tendon transfers. The period of immobilization averaged between 4 and 5 weeks.
Table 1.
Demographic, psychiatric and surgical characteristics of the patient cohort (N=43). Demographic and psychiatric information was taken from the patients’ electronic medical records. Data pertaining to the surgical procedures, the handedness of the patients and the period of immobilization after the surgical procedures were collected at the time of cast removal.
| Demographics | Psychiatric Diagnoses | Surgical Procedures | |||
|---|---|---|---|---|---|
| Sex (M/F) | 38/5 | Depression | 15 | Type | |
| Age (S.D.) | 56 (12) | Anxiety Disorder | 17 | Arthroplasty | 16 |
| Fracture | 12 | ||||
| Fusion | 8 | ||||
| Soft Tissue | 7 | ||||
| Dominant Hand | 27 | ||||
| Days Immobilized (S.D.) | 33 (18) | ||||
Vascular, sudomotor and trophic changes in the surgical limbs
On the day of cast removal the surgical and contralateral limbs were inspected. Table 2 and Figure 1 provide data demonstrating that differences between the limbs for each of these characteristics were found in many but not all patients. Erythema and trophic changes of the nails were relatively common though abnormal sweating was seldom evident based on physical examination. Both edema, defined as a measured circumference at least 0.5cm greater than that of the contralateral hand, and elevated skin temperature, defined as a temperature >1°C above the contralateral hand, were common as well. Most patients had multiple observable changes in the surgical limbs.
Table 2.
Observations of vascular, sudomotor and trophic findings manifest by patients at the time of cast removal (n=43). Also presented is the distribution of the total number of findings displayed by individual patients.
| Type of Finding | # Patients | Total Findings | # Patients |
|---|---|---|---|
| Erythema in surgical hand | 16 | None | 4 |
| Nail growth differences | 16 | 1 | 10 |
| Hair growth differences | 9 | 2 | 11 |
| Sweating in surgical hand | 4 | 3 | 13 |
| Warmth (≥ 1 deg. C) | 18 | 4 | 2 |
| Edema (≥ 0.5 cm increase) | 33 | 5 | 3 |
Figure 1.
Lateralized differences in skin temperature and hand circumference after surgery. These parameters were measured in the hands of patients ipsilateral and contralateral to surgery on the day of cast removal (n=43). Panel A presents temperature data while panel B displays hand circumference data. The plots display the 75th/25th percentiles (boxes), 95th/5th percentiles (whiskers), median (horizontal line), mean (+ sign), and outliers (spheres). ***p<0.001.
Spontaneous and dynamically evoked pain
Patients were asked to rate the average pain in their surgical extremities over the preceding week using a 0–10 NRS scale. These assessments were made at the time of cast removal and one month following cast removal. For the week preceding cast removal the mean average pain intensity was 3.9 and one month later was 3.0 (p=0.08, paired t-test). Even one month from the time of cast removal, 42% (18/43) of patients reported moderate to severe pain in the surgical hand (Figure 2A). Likewise mean dynamic pain at the time of cast removal was 3.5 and one month later was 1.8 (p<0.001, paired t-test). For this measure 23% (10/43) continued to experience moderate to severe pain (Figure 2B).
Figure 2.
Pain reported by patients at the time of cast removal and one month later (n=43). In panel A data are presented showing categorical average pain intensity levels for the week preceding cast removal (open bars) and follow-up one month after cast removal (closed bars). Pain scores were categorized as none (0/10), mild (1–3/10), moderate (4–6/10) and severe (7–10/10). Panel B displays the data for reports of dynamic pain at the time of cast removal and after one month.
The quality of the pain in the operative hands at the time of cast removal and one month later
The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) helped differentiate the post-operative pain as primarily neuropathic versus nociceptive. This scale has been used to detect neuropathic contributions to pain after surgery and other forms of trauma 26, 34. Use of this instrument indicated that 10/43 patients (23%) experienced pain having a neuropathic versus nociceptive character on the day of cast removal, while one month later 15/43 (35%) met LANSS criteria for pain of neuropathic character. Pain intensity for those experiencing pain of nociceptive versus neuropathic character was similar at the time of cast removal (3.6 vs. 4.6, p>0.05), but significantly higher for those experiencing neuropathic symptoms one month after cast removal (2.1 vs. 4.6, P<0.001). Of the 15 patients experiencing pain of neuropathic character one month after cast removal, only 6 had positive LANSS scores at the time of cast removal. Thus in the month following cast removal 9 patients experienced the emergence of pain having neuropathic characteristics, a trend similar to that previously reported for postsurgical patients 34.
Quantitative sensory testing
Figure 3 presents data demonstrating robust decreases in punctate pain thresholds in hands ipsilateral to surgery versus the paired contralateral hands. The average decrease in punctate pain threshold was 36%. Significant reductions in pressure pain thresholds were also found when the stimulus was applied either to the interdigital skin folds (24%) or metacarpophalangeal joints (20%). Finally, an increase in the cold pain threshold was observed (6.1 °C in surgical hands vs. 4.3 °C in the contralateral hands). Thus multiple testing modalities demonstrated a relative pain sensitization of the hand on the operative side.
Figure 3.
Results of quantitative sensory testing (QST) on the hands of patients after surgery and cast immobilization (n=43). Measurements were made on the day of cast removal. Panel A presents data collected using a punctate stimulus, panel B shows cold pain thresholds, panel C provides pain thresholds for pressure applied to the joints, and panel D shows thresholds for the same type of pressure stimulus applied to the interdigital skin folds. The plots display the 75th/25th percentiles (boxes), 95th/5th percentiles (whiskers), median (horizontal line), mean (+ sign), and outliers (spheres). ***p<0.001.
Biochemical markers in skin tissue
Skin biopsies were harvested from both the surgical and contralateral hands at the time of cast removal from 19 patients willing to undergo the biopsy procedure. Processing this tissue for analysis at the mRNA level was conducted for the cytokines IL-1β, IL-6, TNFα, the neurotrophin NGF and the mast cell marker enzyme tryptase. Analysis revealed a statistical increase in IL-6, TNFα and tryptase expression in the surgical hand skin versus the contralateral hand (Figure 4).
Figure 4.
Lateralized differences in skin mediator levels one month after hand surgery. For these analyses 3mm skin biopsies were collected from skin at least 4cm distant from surgical incisions on the dorsal surfaces of the hands at the time of cast removal and sensory measurements. Samples were processed for mRNA analysis, and target mRNA’s were quantified using real-time qPCR. For the purposes of data display the data were normalized to a contralateral side mediator level of 1. The data are displayed as means +/− S. D., *p<0.01.
Exploratory analyses
Our studies were designed primarily to describe physiological and sensory changes occurring in the hands of patients after surgery and immobilization. Our dataset did support, however, exploratory analyses of possible links between patient characteristics, biochemical alterations and sensory changes and our selected pain outcomes.
We first examined correlations between QST parameters and pain outcomes. Table 1 supplemental provides data demonstrating correlations between QST measurements and pain outcomes such as dynamic pain, NRS average pain intensity and LANSS score at the time of cast removal and one month later. Potential correlations were observed between lower punctate pain thresholds in the hands of patients ipsilateral to surgery and both higher dynamic pain ratings as well as higher LANSS scores at the time of cast removal. Likewise, experiencing cold pain at a higher temperature was associated with the same two pain-related outcomes.
Demographic factors may influence susceptibility to CRPS. Because of the nature of the sample, only 5 female patients, we were not able to examine the effect of sex on the outcome parameters. Correlations between age and QST measurements were, however, very suggestive. Inverse (age protective) correlations were observed between age and punctate pain (r2=−0.30, p<0.05) as well as joint pressure (r2=−0.31, p<0.05) and cold (r2=0.37, p<0.05) contralateral-ipsilateral differences at the time of cast removal. Age was poorly correlated with the pain outcomes, though advancing age had a marginal correlation (r2=−0.28, p=0.07) with lower LANSS scores at the time of cast removal.
We also examined the relationship between skin levels of the measured inflammatory mediators and pain outcomes. For these analyses we attempted to correlate the ratio of mediator expression in the skin of surgical vs. contralateral hands with pain outcomes at the time of cast removal and one month later. These revealed correlations between the skin NGF expression ratio and both dynamic (r2=0.55, p<0.05) and NRS (r2=0.55, p<0.05) pain at one month after cast removal along with the skin IL-1β ratio and LANSS at one month after cast removal (r2=0.52, p<0.01).
Discussion
Complex Regional Pain Syndrome is a problematic condition. The condition has its peak incidence in middle age, particularly in women 11, 31, though children can be affected as well 37. Disability is very common in the setting of CRPS, and can be progressive36, 42. The condition itself is enigmatic in its etiology and frequently changes in its clinical characteristics over time 8. Though significant progress has been made using newer rodent CRPS models 15, 27 and by applying carefully designed experimental paradigms to human volunteers in pain laboratories 39, translating these findings into clinical populations has been difficult due to the limited availability of subjects and the heterogeneity of the assembled cohorts in terms of etiological factors, duration of the symptoms and histories of treatment. In the present set of studies we characterized the limbs of patients who underwent hand and wrist surgery followed by several weeks of immobilization, a set of factors known to predispose patients to develop CRPS. Many of the post-surgical patients exhibited CRPS-like changes immediately after cast removal in terms of surgical extremity warmth, edema, pain sensitization and the production of inflammatory mediators in the skin (Figures 1, 2, Table 2). These postsurgical patients may be useful in CRPS research as well as in understanding the broader issue of the transition from acute to chronic postoperative pain.
Pain-related changes occurring after distal upper extremity surgery and cast immobilization were assessed using several approaches. At the time of cast removal most patients had at least mild movement induced pain in the hand, and experienced at least mild pain over the preceding week (Figure 2). This pain decreased over the first month for many patients, but it is remarkable that 42% of patients (18/43) persisted in showing moderate to severe levels of pain (4/10 or greater) 4 weeks after cast removal, or about 8–9 weeks on average from the time of surgery. Though the LANSS questionnaire has important limits in terms of sensitivity and specificity, scores indicated that many patients experienced pain having neuropathic charateristics more than one month after cast removal. Nociceptive-type pain was less severe on average. Evidence of neuropathia was associated with more severe pain in a recent population-based study of persistent postoperative pain 18. Importantly, 9 patients appeared to convert from a primarily nociceptive to a primarily neuropathic-type pain by one month after cast removal. This observation is similar to the increasing neuropathic symptoms observed in patients in the months following thoracotomy 34. The Budapest CRPS diagnostic criteria include the evaluation of patients for signs related to sensory, vasomotor, sudomotor/edema and motor/trophic changes 16. All of our patients showed sensory changes in at least one of the QST tests, and almost all patients had one or more additional signs consistent with the Budapest CRPS criteria (Table 2). Importantly, our study was not designed to determine the incidence of CRPS itself after surgery, particularly at the one month post-cast removal time point. However, the location of pain in non-surgically involved tissues, the neuropathic character of the symptoms, and the observation of trophic and vascular changes in the limbs of many of the patients suggest pain occurring after cast removal in surgical limbs may arise from causes other than those involved in the primary healing process.
The QST testing performed on areas of the hand ≥ 4cm removed from the surgical site demonstrated pain sensitization in the limbs ipsilateral to surgery in comparison to the contralateral limbs (Figure 3). The testing modalities were selected based on the results of testing performed on humans with CRPS in previous studies 13, 14, 35. While no single testing modality shows profound changes in every CRPS patient, mechanical allodynia, cold hyperalgesia and pressure hyperalgesia are found in approximately 30–70% of CRPS patients, and most patients show a combination of modes of sensitization 14. Our measurements demonstrating lateralized decreases in punctate mechanical pain thresholds were clear, and demonstrated a 36% decrease on average. Likewise our pressure pain measurements in joints and inter-digit skin folds showed thresholds reduced 24% and 20% respectively in the ipsilateral versus contralateral hands with most patients showing sensitization in the surgical hand for both these traits. Interestingly, pressure pain threshold was the QST parameter most frequently found to be changed in patients with CRPS1 in a review of the results of 298 patients with this diagnosis 14.
We extended our observations to the biochemical level. Several studies have found that inflammatory mediators, including IL-6 and TNFα are elevated in the venous blood, skin blister, and skin of CRPS-affected limbs 17, 20, 28, 32. These cytokines have been linked to pain or pain sensitization in numerous human and animal studies. We found IL-6 and TNFα expression was significantly increased in the skin of the surgical compared to contralateral limbs, though the range of the increases for these mediators was broad (Figure 4). It was concluded that keratinocytes are the major, but not necessarily only, source of these mediators in a rat tibia fracture/cast immobilization CRPS model 22. Prior studies using this rat model of CRPS also demonstrated elevated levels of IL-1β and NGF in the skin after 4 weeks cast immobilization 24, 30. While we did observe trends towards increases of these mediators, they were not significantly changed. Lastly, prior skin studies in CRPS patients and in the rat fracture/cast CRPS model indicate that mast cell derived tryptase is elevated in the injured extremity 17, 23. Mast cells may act through the liberation of any of a number of mediators in addition to tryptase itself to support pain sensitization including histamine, PGE2, leukotrienes and TNFα 25, 41. The skin biopsies collected after removal of the casts from the surgical patients showed an increase in tryptase expression. Collectively, these results suggest that the biochemical changes in the skin of patients after hand/wrist surgery and immobilization are similar to those observed in CRPS patients.
While this study was designed primarily to examine the physiological, sensory and biochemical changes in the limbs of patients undergoing surgery and extended immobilization, we did perform exploratory analyses attempting to identify interrelationships between the traits and factors we assessed. Limitations in study power restrict our ability to rely on the negative results, and the multiple comparisons intrinsic to performing correlative analysis on large data matrices suggest caution in interpreting positive findings. However, our findings do suggest that QST measures such as punctuate and cold pain thresholds may be related to pain, particularly the neuropathic contributions to that pain experienced in the immediate post-immobilization period. Potentially highly significant for mechanistic studies, the changes in the levels of IL-1β and NGF in skin measured at the time of cast removal appeared to be related to pain experiences up to one month later. Correlations involving NGF may be especially important as they were identified between skin levels of this mediator and dynamic pain as well as average NRS pain over the preceding week. This neurotrophin has been linked strongly to multiple forms of pain including CRPS using a fracture/cast pain model involving 4 weeks of immobilization, an immobilization period similar to the average immobilization imposed on our patients (33 days) 30. Moreover, anti-NGF agents have proven beneficial in controlling pain in clinical populations though concerns over the consequences of long term use have arisen 7, 19, 29, 38. More broadly, it has been suggested that immunotherapies of various types might be helpful in controlling CRPS 4012. If future studies are consistent with the current results it may be reasonable to determine if perioperative or short-term postoperative suppression of cytokine or NGF signaling, or perhaps inhibition of mast cell activity could reduce sub-acute postoperative pain, the occurrence of CRPS or enhance the functional outcomes of limb surgeries.
In this report we provide data demonstrating that the study of patients undergoing distal limb surgery with subsequent immobilization might provide a useful pain model. These patients exhibit CRPS-like changes at least around the time of cast removal, and many experience moderate to severe pain for at least a month afterward. It seems plausible that this model could be used to study approaches to reducing persistent postoperative pain and other CRPS-like changes if not CRPS itself. On the other hand, the diversity of sensory and biochemical changes after this type of surgery and the correlations that likely exist between some of these factors suggest that larger studies or studies focused on specific factors might enlighten us about fundamental mechanisms supporting or suppressing the development of CRPS or persistent postoperative pain. It should be recognized that our study population was predominantly male, distinct from the overall sex distribution of CRPS sufferers10, and psychological disease was common. Though a recent report suggests a lack of effect of sex on the propensity to develop CRPS 3, caution should be used in generalizing our observations. While this model is unlikely to be suitable to address all questions, it is our hope that this or similar approaches may allow fundamental biological and therapeutic discoveries to be made by combining experimental investigations with standard clinical care.
Supplementary Material
Perspective.
This study has identified CPRS-like features in the limbs of patients undergoing surgery followed by immobilization. Further studies using this population may be useful in refining our understanding of CRPS mechanisms and treatments for this condition.
Acknowledgments
This work was funded by the Department of Veterans Affairs grant 1I01RX000340-01.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Disclosures
The authors have no conflicts of interest to disclose.
References
- 1.Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain. 1999;80:539–544. doi: 10.1016/S0304-3959(98)00246-2. [DOI] [PubMed] [Google Scholar]
- 2.Atkins RM, Tindale W, Bickerstaff D, Kanis JA. Quantitative bone scintigraphy in reflex sympathetic dystrophy. Br J Rheumatol. 1993;32:41–45. doi: 10.1093/rheumatology/32.1.41. [DOI] [PubMed] [Google Scholar]
- 3.Beerthuizen A, Stronks DL, Van't Spijker A, Yaksh A, Hanraets BM, Klein J, Huygen FJ. Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture. Pain. 2012;153:1187–1192. doi: 10.1016/j.pain.2012.01.026. [DOI] [PubMed] [Google Scholar]
- 4.Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–157. doi: 10.1016/s0304-3959(00)00482-6. [DOI] [PubMed] [Google Scholar]
- 5.Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6:149–158. doi: 10.1016/j.jpain.2004.11.007. [DOI] [PubMed] [Google Scholar]
- 6.Birklein F, Riedl B, Sieweke N, Weber M, Neundorfer B. Neurological findings in complex regional pain syndromes--analysis of 145 cases. Acta Neurol Scand. 2000;101:262–269. doi: 10.1034/j.1600-0404.2000.101004262x./. [DOI] [PubMed] [Google Scholar]
- 7.Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial. J Pain. 2012 doi: 10.1016/j.jpain.2012.05.006. [DOI] [PubMed] [Google Scholar]
- 8.Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010;113:713–725. doi: 10.1097/ALN.0b013e3181e3db38. [DOI] [PubMed] [Google Scholar]
- 9.da Costa VV, de Oliveira SB, Fernandes Mdo C, Saraiva RA. Incidence of regional pain syndrome after carpal tunnel release. Is there a correlation with the anesthetic technique? Rev Bras Anestesiol. 2011;61:425–433. doi: 10.1016/S0034-7094(11)70050-2. [DOI] [PubMed] [Google Scholar]
- 10.de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129:12–20. doi: 10.1016/j.pain.2006.09.008. [DOI] [PubMed] [Google Scholar]
- 11.de Mos M, Huygen FJ, Dieleman JP, Koopman JS, Stricker BH, Sturkenboom MC. Medical history and the onset of complex regional pain syndrome (CRPS) Pain. 2008;139:458–466. doi: 10.1016/j.pain.2008.07.002. [DOI] [PubMed] [Google Scholar]
- 12.Dirckx M, Stronks DL, Groeneweg G, Huygen FJ. Effect of immunomodulating medications in complex regional pain syndrome: a systematic review. The Clinical journal of pain. 2012;28:355–363. doi: 10.1097/AJP.0b013e31822efe30. [DOI] [PubMed] [Google Scholar]
- 13.Eberle T, Doganci B, Kramer HH, Geber C, Fechir M, Magerl W, Birklein F. Warm and cold complex regional pain syndromes: differences beyond skin temperature? Neurology. 2009;72:505–512. doi: 10.1212/01.wnl.0000341930.35494.66. [DOI] [PubMed] [Google Scholar]
- 14.Gierthmuhlen J, Maier C, Baron R, Tolle T, Treede RD, Birbaumer N, Huge V, Koroschetz J, Krumova EK, Lauchart M, Maihofner C, Richter H, Westermann A. Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain. 2012;153:765–774. doi: 10.1016/j.pain.2011.11.009. [DOI] [PubMed] [Google Scholar]
- 15.Guo TZ, Offley SC, Boyd EA, Jacobs CR, Kingery WS. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain. 2004;108:95–107. doi: 10.1016/j.pain.2003.12.010. [DOI] [PubMed] [Google Scholar]
- 16.Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8:326–331. doi: 10.1111/j.1526-4637.2006.00169.x. [DOI] [PubMed] [Google Scholar]
- 17.Huygen FJ, Ramdhani N, van Toorenenbergen A, Klein J, Zijlstra FJ. Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1. Immunol Lett. 2004;91:147–154. doi: 10.1016/j.imlet.2003.11.013. [DOI] [PubMed] [Google Scholar]
- 18.Johansen A, Romundstad L, Nielsen CS, Schirmer H, Stubhaug A. Persistent postsurgical pain in a general population: prevalence and predictors in the Tromso study. Pain. 2012;153:1390–1396. doi: 10.1016/j.pain.2012.02.018. [DOI] [PubMed] [Google Scholar]
- 19.Katz N, Borenstein DG, Birbara C, Bramson C, Nemeth MA, Smith MD, Brown MT. Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain. 2011;152:2248–2258. doi: 10.1016/j.pain.2011.05.003. [DOI] [PubMed] [Google Scholar]
- 20.Kramer HH, Eberle T, Uceyler N, Wagner I, Klonschinsky T, Muller LP, Sommer C, Birklein F. TNF-alpha in CRPS and 'normal' trauma--significant differences between tissue and serum. Pain. 2011;152:285–290. doi: 10.1016/j.pain.2010.09.024. [DOI] [PubMed] [Google Scholar]
- 21.Leard JS, Breglio L, Fraga L, Ellrod N, Nadler L, Yasso M, Fay E, Ryan K, Pellecchia GL. Reliability and concurrent validity of the figure-of-eight method of measuring hand size in patients with hand pathology. J Orthop Sports Phys Ther. 2004;34:335–340. doi: 10.2519/jospt.2004.34.6.335. [DOI] [PubMed] [Google Scholar]
- 22.Li WW, Guo TZ, Li XQ, Kingery WS, Clark JD. Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain. 2010;151:843–852. doi: 10.1016/j.pain.2010.09.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Li WW, Guo TZ, Liang DY, Sun Y, Kingery WS, Clark JD. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology. 2012;116:882–895. doi: 10.1097/ALN.0b013e31824bb303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li WW, Sabsovich I, Guo TZ, Zhao R, Kingery WS, Clark JD. The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain. 2009;144:303–313. doi: 10.1016/j.pain.2009.04.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Machelska H. Dual peripheral actions of immune cells in neuropathic pain. Arch Immunol Ther Exp (Warsz) 2011;59:11–24. doi: 10.1007/s00005-010-0106-x. [DOI] [PubMed] [Google Scholar]
- 26.Mercer SJ, Chavan S, Tong JL, Connor DJ, de Mello WF. The early detection and management of neuropathic pain following combat injury. J R Army Med Corps. 2009;155:94–98. doi: 10.1136/jramc-155-02-03. [DOI] [PubMed] [Google Scholar]
- 27.Millecamps M, Laferriere A, Ragavendran JV, Stone LS, Coderre TJ. Role of peripheral endothelin receptors in an animal model of complex regional pain syndrome type 1 (CRPS-I) Pain. 2010;151:174–183. doi: 10.1016/j.pain.2010.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Munnikes RJ, Muis C, Boersma M, Heijmans-Antonissen C, Zijlstra FJ, Huygen FJ. Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm. 2005;2005:366–372. doi: 10.1155/MI.2005.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nagashima H, Suzuki M, Araki S, Yamabe T, Muto C. Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study. Osteoarthritis Cartilage. 2011;19:1405–1412. doi: 10.1016/j.joca.2011.09.006. [DOI] [PubMed] [Google Scholar]
- 30.Sabsovich I, Wei T, Guo TZ, Zhao R, Shi X, Li X, Yeomans DC, Klyukinov M, Kingery WS, Clark JD. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain. 2008;138:47–60. doi: 10.1016/j.pain.2007.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain. 2003;103:199–207. doi: 10.1016/s0304-3959(03)00065-4. [DOI] [PubMed] [Google Scholar]
- 32.Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. The Clinical journal of pain. 2006;22:235–239. doi: 10.1097/01.ajp.0000169669.70523.f0. [DOI] [PubMed] [Google Scholar]
- 33.Schwartzman RJ, Erwin KL, Alexander GM. The natural history of complex regional pain syndrome. Clin J Pain. 2009;25:273–280. doi: 10.1097/AJP.0b013e31818ecea5. [DOI] [PubMed] [Google Scholar]
- 34.Searle RD, Simpson MP, Simpson KH, Milton R, Bennett MI. Can chronic neuropathic pain following thoracic surgery be predicted during the postoperative period? Interact Cardiovasc Thorac Surg. 2009;9:999–1002. doi: 10.1510/icvts.2009.216887. [DOI] [PubMed] [Google Scholar]
- 35.Sethna NF, Meier PM, Zurakowski D, Berde CB. Cutaneous sensory abnormalities in children and adolescents with complex regional pain syndromes. Pain. 2007;131:153–161. doi: 10.1016/j.pain.2006.12.028. [DOI] [PubMed] [Google Scholar]
- 36.Sharma A, Agarwal S, Broatch J, Raja SN. A web-based cross-sectional epidemiological survey of complex regional pain syndrome. Reg Anesth Pain Med. 2009;34:110–115. doi: 10.1097/AAP.0b013e3181958f90. [DOI] [PubMed] [Google Scholar]
- 37.Stanton-Hicks M. Plasticity of complex regional pain syndrome (CRPS) in children. Pain Med. 2010;11:1216–1223. doi: 10.1111/j.1526-4637.2010.00910.x. [DOI] [PubMed] [Google Scholar]
- 38.Te AE. A study to investigate tanezumab in patients with interstitial cystitis/painful bladder syndrome. Curr Urol Rep. 2011;12:245–246. doi: 10.1007/s11934-011-0194-0. [DOI] [PubMed] [Google Scholar]
- 39.Terkelsen AJ, Bach FW, Jensen TS. Experimental forearm immobilization in humans induces cold and mechanical hyperalgesia. Anesthesiology. 2008;109:297–307. doi: 10.1097/ALN.0b013e31817f4c9d. [DOI] [PubMed] [Google Scholar]
- 40.Terkelsen AJ, Bach FW, Jensen TS. Experimental forearm immobilization in humans reduces capsaicin-induced pain and flare. Brain Res. 2009;1263:43–49. doi: 10.1016/j.brainres.2009.01.054. [DOI] [PubMed] [Google Scholar]
- 41.van Diest SA, Stanisor OI, Boeckxstaens GE, de Jonge WJ, van den Wijngaard RM. Relevance of mast cell-nerve interactions in intestinal nociception. Biochim Biophys Acta. 2012;1822:74–84. doi: 10.1016/j.bbadis.2011.03.019. [DOI] [PubMed] [Google Scholar]
- 42.Vaneker M, Wilder-Smith OH, Schrombges P, Oerlemans HM. Impairments as measured by ISS do not greatly change between one and eight years after CRPS 1 diagnosis. Eur J Pain. 2006;10:639–644. doi: 10.1016/j.ejpain.2005.10.003. [DOI] [PubMed] [Google Scholar]
- 43.Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012–1016. doi: 10.1016/0140-6736(93)92877-v. [DOI] [PubMed] [Google Scholar]
- 44.Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804. doi: 10.1111/j.1365-2702.2005.01121.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




